×
Back to Agenda
S40 : Toward the Better Timing and Necessary Measures to Initiate Pediatric Drug Development: For the Well-being of Pediatric Patients
Session Chair(s)
Kayoko Kikuchi
Translational Research Headquarters,Center for Translational Research, FUJITA HEALTH UNIVERSITY, Japan
Speaker(s)
Ayumu Arakawa
Head of physicians, National Cancer Center Hospital, Japan
Katsuaki Ura
Deputy Director, Office of International Regulatory Affairs, Ministry of Health, Labour and Welfare (MHLW), Japan
Mariko Kozai, MPHARM
Regulatory Affairs, Pfizer R&D Japan, Japan
Hidefumi Nakamura, MD, PHD
Director for Clinical R&D,, National Center for Child Health and Development, Japan
Kana Harada
Child Life Specialist, Toho University Omori Medical Center, Japan
Have an account?